Brief: Lineage Cell Therapeutics Says Pricing Of Sale Of 2.4 Mln Shares Of Common Stock Of Oncocyte Corp At Price To Buyers Of $2.156 Per Share

Lineage Cell Therapeutics

03/01/2020 01:07

Jan 2 (Reuters) - Lineage Cell Therapeutics Inc  LCTX.A :
    * LINEAGE CELL THERAPEUTICS CONDUCTS SALE OF SHARES IN
ONCOCYTE
CORPORATION
    * LINEAGE CELL THERAPEUTICS-PRICING OF SALE OF 2.4 MILLION
SHARES
OF COMMON STOCK OF ONCOCYTE CORPORATION AT PRICE TO BUYERS OF
$2.156PER SHARE

Source text for Eikon:  ID:nBw2yFy6Va 
Further company coverage:  LCTX.A 

 ((Reuters.Briefs@thomsonreuters.com;))